Location History:
- Yangpu District, CN (2021 - 2023)
- Shanghai, CN (2021 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: Innovations and Contributions of Inventor Zaixing Li
Introduction
Zaixing Li is a prominent inventor based in the Yangpu District of China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of six patents to his name, his work has garnered attention in the scientific community.
Latest Patents
Li's latest patents include innovative compounds such as Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate, which serve as Ca1.2 activators. Additionally, he has developed crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, which act as Raf inhibitors for cancer treatment. These inventions are crucial for advancing therapeutic options in oncology.
Career Highlights
Zaixing Li is currently associated with Novartis AG, a leading global healthcare company. His role involves research and development of innovative pharmaceutical solutions. His expertise in medicinal chemistry has been instrumental in the creation of new drug formulations.
Collaborations
Li has collaborated with notable colleagues such as Liladhar Murlidhar Waykole and Sung David C Kim. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in cancer treatment.
Conclusion
Zaixing Li's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving cancer therapies. His work continues to inspire advancements in medical science and offers hope for better treatment options.